TI-RADS分类联合血清TSH、TPOAb、TgAb检测对甲状腺良恶性结节的诊断价值

摘要 目的：分析甲状腺影像报告和数据系统（TI-RADS）分类联合血清促甲状腺激素（TSH）、甲状腺过氧化物酶抗体（TPOAb）、甲状腺球蛋白抗体（TgAb）检测对甲状腺良恶性结节的诊断价值。方法：回顾性分析2019年1月至2021年1月中国人民解放军联勤保障部队解放军第九〇一医院收治的76例甲状腺结节患者的临床资料。术后病理结果显示32例为甲状腺恶性结节（恶性组）,44例为良性结节（良性组）。对比两组超声征象以及血清TSH、TPOAb、TgAb的表达情况。甲状腺恶性结节的影响因素通过多因素Logistic回归进行分析,TI-RADS分类联合TSH、TPOAb、TgAb检测对甲状腺良恶性结节的诊断价值通过受试者工作特征（ROC）曲线进行评估。结果：恶性组结节质地为实性、边界模糊/毛刺、微钙化、内部回声为低回声、纵横比＞1、TI-RADS分类≥4类占比明显高于良性组（P＜0.05）,而两组结节直径、结节数目比较无差异（P＞0.05）。恶性组TSH、TPOAb、TgAb水平均高于良性组（P＜0.05）。多因素Logistic回归分析结果显示,质地为实性、边界模糊/毛刺、微钙化、内部回声为低回声、纵横比＞1、TI-RADS分类≥4类、高TSH、高TPOAb、高TgAb水平为甲状腺恶性结节的危险因素（P＜0.05）。ROC曲线结果显示,TI-RADS分类、TSH、TPOAb、TgAb联合检测较各指标单独检测的诊断效能更高。结论：TI-RADS分类联合血清TSH、TPOAb、TgAb检测可有效鉴别甲状腺结节性质,且联合检测诊断效能更高。     

Interaction between gene A-positive Helicobacter pylori and human leukocyte antigen II alleles increase the risk of Graves disease in Chinese Han population: An association study

Objective

The current study explored the correlation of Helicobacter pylori and the polymorphisms of human leukocyte antigen II (HLA-II) alleles with Graves disease (GD).

Methods

A total of 216 patients with GD were recruited. 102 healthy volunteers constituted the control group. Levels of H. pylori immunoglobulin G (IgG) antibodies and H. pylori cytotoxin-associated gene A (CagA) IgG antibodies were detected using enzyme-linked immunosorbent assays. Molecular typing of the HLA-II alleles was conducted using polymerase chain reaction with sequence specific primers.

Results

H. pylori, particularly CagA-positive strains, HLA-DQA1*0201, and HLA-DQA1*0501 were associated with GD (P = 0.015, OR = 1.811; P = 0.000, OR = 3.085; P = 0.000, OR = 0.315; and P = 0.004, OR = 2.844, respectively). Patients with CagA-positive H. pylori and negative HLA-DQA1*0201 or positive HLA-DQA1*0501 were more likely exposed to GD compared with those with only one of these indices.

Conclusion

CagA-positive H. pylori, negative HLA-DQA1*0201, or positive HLA-DQA1*0501 may increase the risk of GD.     

Positive Thyroid Peroxidase Antibody and Thyroglobulin Antibody are Associated With Better Clinicopathologic Features of Papillary Thyroid Cancer

ObjectiveTo compare the thyroid autoantibody status of patients with papillary thyroid cancer (PTC) and benign nodular goiter as well as possible associations between thyroid autoantibodies and clinicopathologic features of PTC.MethodsA total of 3934 participants who underwent thyroidectomy were enrolled in this retrospective study. Patients were divided into PTC and benign nodule groups according to pathological diagnosis. Based on the preoperative serum antibody results, PTC patients were divided into thyroid peroxidase antibody (TPOAb)-positive, thyroglobulin antibody (TgAb)-positive, dual TPOAb- and TgAb-positive, or antibody-negative groups.ResultsOf the 3934 enrolled patients, 2926 (74.4%) were diagnosed with PTC. Multivariate regression analyses suggested that high thyroid-stimulating hormone levels (adjusted odds ratio [OR] = 1.732, 95% CI [1.485-2.021], P < .001), positive TgAb (adjusted OR = 1.768, 95% CI [1.436-2.178], P < .001), and positive TPOAb (adjusted OR = 1.452, 95% CI [1.148-1.836], P = .002) were independent risk factors for predicting malignancy of thyroid nodules. Multinomial multiple logistic regression analyses indicated that positive TPOAb alone was an independent predictor of less central lymph node metastasis in PTC patients (adjusted OR = 0.643, 95% CI [0.448-0.923], P = .017), whereas positive TgAb alone was significantly associated with less extrathyroidal extension (adjusted OR = 0.778, 95% CI [0.622-0.974], P = .028). PTC patients with dual-positive TPOAb and TgAb displayed a decreased incidence of extrathyroidal extension (adjusted OR = 0.767, 95% CI [0.623-0.944], P = .012) and central lymph node metastasis (adjusted OR = 0.784, 95% CI [0.624-0.986], P = .037).ConclusionAlthough preoperative positive TPOAb and TgAb are independent predictive markers for PTC, they are also associated with better clinicopathologic features of PTC.